Condition: IBS (Irritable Bowel Syndrome) · Sponsor: PGP Health
This prospective, interventional trial is intended to determine the safety and effectiveness of the Variable Compression System (VCS) device for Irritable Bowel Syndrome (IBS). This pilot study will enroll 20 subjects who will be required to wear the VCS device for a minimum of 6 hours a day and follow up at 21 days, 8 weeks, and 6 months post-device administration.
This description comes directly from the study's public registry record.
Agim Beshiri, MD · +12623448468 · agim.beshiri@cmoproconsult.com
Always discuss trial participation with your own doctor first.
| Central Florida Gastro Research | Kissimmee, Florida, United States | Recruiting |
| UChicago Medicine AdventHealth Medical Group Gastroenterology at Bolingbrook | Bolingbrook, Illinois, United States | Recruiting |
| Delta Gastroenterology PC | Southhaven, Mississippi, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07540312